On June 15, the Medicaid and CHIP Payment and Access Commission (MACPAC) issued its June 2018 Report to Congress on Medicaid and CHIP. The MACPAC report included recommendations for two sound, albeit modest, improvements to the highly effective Medicaid drug rebate program which could lower state and federal Medicaid prescription drug costs: Prevent manufacturers of […]
As I’ve previously written, the Medicaid drug rebate program is very effective. It requires drug manufacturers to provide sizable rebates that significantly lower federal and state Medicaid prescription drug costs while ensuring access to needed medications for tens of millions of low-income beneficiaries. Last week, the Medicare Trustees issued their latest annual report on the […]
Nearly a quarter of U.S. children use at least one prescription drug a month, most commonly treating such conditions as asthma, attention deficit hyperactivity disorder, and infections. Medicaid guarantees that enrolled children who need drugs receive them without any financial barriers, while some in the Children’s Health Insurance Program have a modest copayment. This report, the third in a […]
